Back to Search Start Over

Is obesity considered for thromboprophylaxis prescription? A post-hoc analysis of the SiFMI 2017 study.

Authors :
Giraud V
Cohen-Aubart F
Puyade M
Bourgarit A
Martin M
Source :
Thrombosis research [Thromb Res] 2022 Oct; Vol. 218, pp. 138-141. Date of Electronic Publication: 2022 Aug 15.
Publication Year :
2022

Abstract

Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Subjects

Subjects :
Anticoagulants therapeutic use
Humans
Obesity complications
Obesity drug therapy
Postoperative Complications prevention & control
Prescriptions
Venous Thromboembolism drug therapy
Venous Thromboembolism prevention & control

Details

Language :
English
ISSN :
1879-2472
Volume :
218
Database :
MEDLINE
Journal :
Thrombosis research
Publication Type :
Editorial & Opinion
Accession number :
36037549
Full Text :
https://doi.org/10.1016/j.thromres.2022.08.013
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details